Neoplasia/BPH

	Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study. Cancer Rep (Hoboken) Kawahara T, Nagumo Y, Yamaguchi A, Hamada K, Tanuma K, Nitta S, Shiga M, Ikeda A, Kandori S, Hoshi A, Nishiyama H. PMID: 41578675 [PubMed - indexed for MEDLINE]
	Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience. Ann Med Wu J, Cao CZ, Cui HL, Chen MX, Gao LN, Zheng S, Zhou AP, Guan YY, Bi XG, Shi HZ, Shou JZ. PMID: 41578672 [PubMed - indexed for MEDLINE]
	Causal association between socioeconomic disparities and tumors of the urinary system: A Mendelian randomization study. Medicine (Baltimore) Chen WW, Wu B, Wen X. PMID: 41578463 [PubMed - indexed for MEDLINE]
	Prediction of renal cell carcinoma: Development and validation of machine learning model. Medicine (Baltimore) Zheng T, Xu R, Zhang J, Xu Y, Zeng C, Zhang Z. PMID: 41578457 [PubMed - indexed for MEDLINE]
	Physician Preferences Regarding Integration of Life Expectancy in Prostate Cancer Management. J Gen Intern Med Heard JR, Chaplin A, Luu M, Khodyakov D, Spiegel B, Freedland S, Daskivich TJ. PMID: 41578109 [PubMed - as supplied by publisher]
	Population-Based analysis of conditional survival patterns and dynamic prognostic modeling in primary urinary tract lymphoma. Ann Hematol Ke R, Nan C. PMID: 41577855 [PubMed - indexed for MEDLINE]
	Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective Study. Eur Urol Oncol Mezepo G, Khene ZE, Boustani J, Kleinclauss F, Quivrin M, Neftah Y, Mercier J, Bajeot AS, Mardelli C, Pradere B, Seisen T, Hammoud Y, Bouvier E, Jacquey H, Choffel L, Palkowski T, Khalifa J, Benyoucef A, Pasquier D, Brassart C, Marcq G, Khalladi N, Coutte A, Sargos P, Huck C, Rouprêt M, Roumiguie M, French Committee of Urologic Oncology (CCAFU). PMID: 41577610 [PubMed - as supplied by publisher]
	[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]. Bull Cancer Neuzillet Y, Thibault C, Mourey L, Joly C, Balardy L, Faix A, Raynard B, Chaouachi H, Bousquet M, Rioufol C, Alexandre J, Fiard G, Joly F. PMID: 41577490 [PubMed - as supplied by publisher]
	Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer. BJU Int Kniep C, Maurer T, Hartwieg BF, Mandel P, Wenzel M, Falkenbach F, Krpina K, Budäus L, Haese A, Salomon G, Steuber T, Graefen M, Tilki D, Preisser F. PMID: 41577442 [PubMed - as supplied by publisher]
	Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data. JCO Precis Oncol Rizzo M, Pezzicoli G, Porta C, Povero M, Pradelli L, Sicari E, Barbiero VS, Porta C. PMID: 41576306 [PubMed - indexed for MEDLINE]
	Focal Cryotherapy in Prostate Cancer. Does Gleason Impact Results? Int Braz J Urol Mate K, de Pablos-Rodríguez P, Herraiz MB, Román MH, Gómez PP, Fons AC, García MIM, Aliaga JP, Cortés MB, Lozano ÁG, Escrig S JLD, Castañé CG, Part VR, Borja JLCR. PMID: 41576188 [PubMed - indexed for MEDLINE]
	Robot-assisted Partial Nephrectomy with and without Mixed Reality - REALITATEM study. Int Braz J Urol Duarte DM Junior, Brum PW, Berger M, Kowalski A, Silva B Neto, Berger AK. PMID: 41576183 [PubMed - indexed for MEDLINE]
	Transperineal Laser Ablation for Treatment of Lower Urinary Tract Symptoms in Benign Prostate Enlargement: A Systematic Review and Meta-analysis. Int Braz J Urol Pires IZ, Gobbo MODS, Fujimura AY Jr, Milbradt TL, Sudo RYU, Pereira M, Marquardt N Filho, Carvalhal GF, Averbeck MA. PMID: 41576182 [PubMed - indexed for MEDLINE]
	Comment on "The role of apparent diffusion coefficient values in diagnosing prostate cancer for patients with equivocal PI-RADS 3 lesions: a multicenter retrospective study". Int J Surg Wang A. PMID: 41576064 [PubMed - as supplied by publisher]
	Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis. Target Oncol Fukushima H, Yajima S, Chen W, Hirakawa A, Tanabe K, Fujiwara M, Arita Y, Tanaka H, Masuda H, Fujii Y, Yoshida S. PMID: 41575641 [PubMed - as supplied by publisher]
	P.I. nomogram: an exploratory imaging-derived model for predicting early urinary incontinence following ThuLEP. World J Urol Lan XD, Jiang R, Wang H, Mulati Y, Zhang K, Zhang Q, Wu J, Meng Y, Meng YS. PMID: 41575593 [PubMed - indexed for MEDLINE]
	Decision tree models combining Bi-parametric vesical imaging reporting and data system and apparent diffusion coefficient metrics for predicting muscle-invasive bladder cancer. Abdom Radiol (NY) Sugawara D, Hatakeyama K, Konno M, Tozawa T, Sato T, Murata T, Murasawa E, Narita S, Nanjo H, Habuchi T, Mori N. PMID: 41575494 [PubMed - as supplied by publisher]
	TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists. Adv Anat Pathol Przybycin CG, Nguyen JK, Alaghehbandan R. PMID: 41574499 [PubMed - as supplied by publisher]
	Recent Advances in Understanding the Biological Role of microRNA-371a-3p in Testicular Germ Cell Tumors. Andrology Klemke M, Belge G, Dieckmann KP. PMID: 41574394 [PubMed - as supplied by publisher]
	The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies. Front Oncol Wang B, Zhang Y, Zhang W. PMID: 41573638 [PubMed]

Articles 1 - 20 / 184864

Page 1 of 9244



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy